Early Development Services Brochure

As a global strategic partner for pharmaceutical and biotech companies, PRA is transforming the clinical trial landscape across all phases of drug development. Our globally harmonized service is delivered by highly knowledgeable employees who are experienced in the techniques required for bioanalytical laboratory studies and Phase I-IIa clinical research.

Our high standards of excellence and scientific expertise are demonstrated within our state-of-the-art facilities in Europe (Assen, Zuidlaren and Groningen, The Netherlands) and North America (Lenexa, Kansas), and with our Unit-on-Demand model in Central and Eastern Europe, which is dedicated to patient Phase I-IIa trials.

These facilities provide the perfect environment required for complex compound development and testing for the pharmaceutical and biotech industries. All are equipped with the latest technologies, diagnostic tools and infrastructure.

The strategic locations of the GLP-certified laboratories close to our Phase I Clinical Research Units facilitate an innovative working collaboration that enables time-critical samples to be analyzed within rapid turnaround timeframes. This efficient analysis enables clients to progress studies much faster, clearly differentiating the joint setup of our bioanalytical laboratory and clinical research units.